International Patent: SALT FORM OF HETEROCYCLIC ANTITUMOR COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF

GENEVA, July 1 -- CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. filed a patent application (CN2025/141941) for “SALT FORM OF HETEROCYCLIC ANTITUMOR COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF”. With publication no. WO/2026/124615, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 471/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....